| D2 | The effectiveness of community-based multi-month dispensing of antiretroviral treatment with single annual clinical visits for newly stable HIV patients: a pooled analysis of two cluster-randomized trials in Southern Africa | E-poster | Impact evaluation of differentiated service delivery |
| D2 | Differentiated HIV care for people using second-line antiretroviral therapy in South Africa: a retrospective cohort study | E-poster | Impact evaluation of differentiated service delivery |
| D2 | Scale-up of multi-month dispensation of antiretroviral therapy among children living with HIV as a COVID-19 mitigation measure and retention strategy, Zambia, 2020 | E-poster | Impact evaluation of differentiated service delivery |
| D2 | An evaluation of nurse-led Community ART Distribution (CAD) for stable ART clients in Malawi | E-poster | Impact evaluation of differentiated service delivery |
| D2 | Impact of a family-centered care model on viral suppression among HIV-infected children in Migori, Kenya | E-poster | Impact evaluation of differentiated service delivery |
| D2 | Clinical outcomes of community ART distribution: DRC's experience with the PODI+ model | E-poster | Impact evaluation of differentiated service delivery |
| D2 | Cost-effectiveness of community delivery of HIV care in South Africa | E-poster | Impact evaluation of differentiated service delivery |
| D2 | Does onsite HIV self-testing enhance linkage to care? A case study of HIVST Challenge Fund Project in Kenya | E-poster | Impact evaluation of differentiated service delivery |
| D2 | Optimizing transitioning to differentiated service delivery key approach to achieving (UNAIDS) 90-90-90 treatment targets in Kogi State, Nigeria | E-poster | Impact evaluation of differentiated service delivery |
| D2 | Differentiated prevention testing and art delivery for modified general populations and key populations in Nigeria: a documentation of best practice models | E-poster | Impact evaluation of differentiated service delivery |